Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8815830
Nucleosides with antiviral and anticancer activity
granted -
US 8815845
1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
granted -
US 8815848
Compositions and methods for inhibition of the JAK pathway
granted -
US 8815558
Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
granted -
US 8815246
Fc receptor binding proteins
granted -
US 8815240
Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
granted -
US 8815511
Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate
granted -
US 8815227
Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom
granted -
US 8815226
Protein-polymer-drug conjugates
granted -
US 8816058
Polynucleotides encoding anti-CD100 antibodies or antigen-binding fragments thereof
granted -
US 8816088
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
granted -
US 8816077
Oligomer-protein tyrosine kinase inhibitor conjugates
granted -
US 8816071
Tocotrienol derivatives and associated methods
granted -
US 8816046
Compositions and methods for CaMKII inhibitors and uses thereof
granted -
US 8815885
Methods and compositions for modulating IRE1, SRC, and ABL activity
granted -
US 8815229
Granulysin in immunotherapy
granted -
US 8815801
Controlled release composition and method of producing the same
granted -
US 8815866
Aminopyridine kinase inhibitors
granted -
US 8815907
Quaternary ammonium compounds useful as muscarinic receptor antagonists
granted -
US 8816091
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound
granted -
US 8816151
Stat5b transgenic mice and methods of use thereof
granted -
US 8815212
Nanocarriers for imaging and therapy applications
granted -
US 8808679
Auristatin compounds and conjugates thereof
granted -
US 8809292
Compositions and methods for inhibiting expression of the PCSK9 gene
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.